Company Analysis Danaher Corporation
1. Summary
Advantages
- The stock's return over the last year (-18.47%) is higher than the sector average (-31.87%).
- Current debt level 21.99% is below 100% and has decreased over 5 years from 35%.
- The company's current efficiency (ROE=8.87%) is higher than the sector average (ROE=-80.86%)
Disadvantages
- Price (202.18 $) is higher than fair price (61.59 $)
- Dividends (0.4362%) are below the sector average (1.32%).
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| Danaher Corporation | Healthcare | Index | |
|---|---|---|---|
| 7 days | -3.7% | -2.2% | 0.5% |
| 90 days | -15.5% | -33.2% | 3.8% |
| 1 year | -18.5% | -31.9% | 23.4% |
DHR vs Sector: Danaher Corporation has outperformed the "Healthcare" sector by 13.39% over the past year.
DHR vs Market: Danaher Corporation has significantly underperformed the market by -41.86% over the past year.
Stable price: DHR is not significantly more volatile than the rest of the market on "New York Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: DHR with weekly volatility of -0.3552% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (202.18 $) is higher than the fair price (61.59 $).
Price is higher than fair: The current price (202.18 $) is 69.5% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (43.42) is lower than that of the sector as a whole (114.5).
P/E vs Market: The company's P/E (43.42) is lower than that of the market as a whole (70.26).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (3.2) is lower than that of the sector as a whole (9.4).
P/BV vs Market: The company's P/BV (3.2) is lower than that of the market as a whole (22.61).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (7.09) is higher than that of the sector as a whole (4.08).
P/S vs Market: The company's P/S indicator (7.09) is lower than that of the market as a whole (15.24).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (35.53) is higher than that of the sector as a whole (17.79).
EV/Ebitda vs Market: The company's EV/Ebitda (35.53) is higher than that of the market as a whole (24.37).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 1.36% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (1.36%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-59.58%).
5.4. ROE
ROE vs Sector: The company's ROE (8.87%) is higher than that of the sector as a whole (-80.86%).
ROE vs Market: The company's ROE (8.87%) is lower than that of the market as a whole (18.07%).
5.5. ROA
ROA vs Sector: The company's ROA (5.61%) is lower than that of the sector as a whole (6.71%).
ROA vs Market: The company's ROA (5.61%) is lower than that of the market as a whole (6.49%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (10.6%) is lower than that of the sector as a whole (15.68%).
ROIC vs Market: The company's ROIC (10.6%) is higher than that of the market as a whole (9.31%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0.4362% is below the average for the sector '1.32%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 0.4362% has been steadily paid over the past 7 years, DSI=1.
Dividend growth: Company's dividend yield 0.4362% has been growing over the last 5 years. Growth over 10 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (19.7%) are at an uncomfortable level.
8. Insider trades
8.1. Insider trading
Insider Buying Exceeds insider sales by 100% over the last 3 months.
8.2. Latest transactions
| Transaction date | Insider | Type | Price | Volume | Quantity |
|---|---|---|---|---|---|
| 07.02.2025 | SPOON ALAN G Director |
Purchase | 206.46 | 113 553 | 550 |
| 25.04.2024 | Weidemanis Joakim Executive Vice President |
Sale | 250.46 | 5 618 570 | 22 433 |
| 25.04.2024 | Weidemanis Joakim Executive Vice President |
Purchase | 58.48 | 1 311 880 | 22 433 |
| 28.07.2023 | Zerhouni Elias A. Director |
Purchase | 50.8 | 177 292 | 3 490 |
| 28.07.2023 | Raskas Daniel SVP - Corporate Development |
Sale | 260.65 | 2 922 670 | 11 213 |
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
